Peer-Reviewed Publication
Int J Environ Res Public Health2026;23(6)June 5, 2026Journal Article
The Stellate Ganglion Block for PTSD: A Retrospective Clinical Case Series.
Michael Hollifield1,2,3, Jennifer Lai-Trzebiatowski1, Michael Alkire1, Tyler C Smith4, Christine J Eickhoff5, Nima Fahimian1, Rostam Khoshsar1,6, Rajika Tobey1, Staci Becker1, Rossean C Rossel1, Sarah Madison1,7, Patrick Wu1, Amy Treadwell1, Christopher Reist1,8
1Tibor Rubin VA Medical Center, 5901 E. 7th St, Long Beach, CA 90822, USA.
2Department of Psychiatry and Behavioral Sciences, George Washington School of Medicine & Health Sciences, Washington, DC 20052, USA.
3The War Survivors Institute, 5813 E. 2nd Street, #637, Long Beach, CA 90803, USA.
4Department of Health Services and Leadership, School of Health Professions, National University, San Diego, CA 92107, USA.
5The Veterans Health Administration, National Center for Healthcare Advancement and Partnerships, Washington, DC 20420, USA.
6BioHealth Pain Management, 15901 Hawthorne Blvd., Suite 240, Lawndale, CA 90260, USA.
7Anesthesia Associates Medical Group, 5276 Hollister Avenue, Suite 308, Santa Barbara, CA 93111, USA.
8Science 37, 800 Park Office, Suite 3606, Durham, NC 27709, USA.
Abstract
BACKGROUND/OBJECTIVES: Extant data suggest that the Stellate Ganglion Block (SGB) is effective for posttraumatic stress disorder (PTSD). Clinical data from a large healthcare system are lacking. We report data from a clinical project in the Veterans Health Administration.
METHODS: Retrospective data of PTSD and anxiety for 579 patients who received one or more SGBs were analyzed on the full sampl…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans